Validation pour Ingenuity376

vers la météo de la validation par utilisateur

Ingenuity376

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 69 - PMID ?

NODE , an activator of SP NODE protein , has been approved to treat skin manifestation associated with lymphoma .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

     +------------------------SUBJ:V_PASS-N------------------------+                                                          
     |             +--------COMP:N-N(of)-------+                   |                                                          
     |             |           +-MOD_ATT:N-ADJ-+                   +COMP:V_PASS-N(t+                                          
     +----APPOS----+           |       +MOD_ATT+                   |         +MOD_A+----SUBJ:V_PASS-N----+COMP:V_PASS-N(+     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(to) (approve,skin)
MOD_ATT:N-N (skin,treat)
SUBJ:V_PASS-N (associate,skin)
COMP:V_PASS-N(with) (associate,lymphoma)

Analyse 1

     +------------------------SUBJ:V_PASS-N------------------------+                                                          
     |             +--------COMP:N-N(of)-------+                   +-----------------COMP:V_PASS-N(with)----------------+     
     |             |           +-MOD_ATT:N-ADJ-+                   +COMP:V_PASS-N(t+                                    |     
     +----APPOS----+           |       +MOD_ATT+                   |         +MOD_A+----SUBJ:V_PASS-N----+              |     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(to) (approve,skin)
COMP:V_PASS-N(with) (approve,lymphoma)
MOD_ATT:N-N (skin,treat)
SUBJ:V_PASS-N (associate,skin)

Analyse 2

                   +--------COMP:N-N(of)-------+                                                                              
                   |           +-MOD_ATT:N-ADJ-+                                                                              
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PA+OBJ:V+----SUBJ:V_PASS-N----+COMP:V_PASS-N(+     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-V(to) (approve,treat)
OBJ:V-N (treat,skin)
SUBJ:V_PASS-N (associate,skin)
COMP:V_PASS-N(with) (associate,lymphoma)

Analyse 3

     +------------------------SUBJ:V_PASS-N------------------------+                                                          
     |             +--------COMP:N-N(of)-------+                   |                                                          
     |             |           +-MOD_ATT:N-ADJ-+                   +COMP:V_PASS-N(t+-----------COMP:N-N(with)-----------+     
     +----APPOS----+           |       +MOD_ATT+                   |         +MOD_A+----SUBJ:V_PASS-N----+              |     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(to) (approve,skin)
MOD_ATT:N-N (skin,treat)
COMP:N-N(with) (skin,lymphoma)
SUBJ:V_PASS-N (associate,skin)

Analyse 4

                   +--------COMP:N-N(of)-------+                                                                              
                   |           +-MOD_ATT:N-ADJ-+                             +--------------COMP:V-N(with)--------------+     
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PA+OBJ:V+----SUBJ:V_PASS-N----+              |     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-V(to) (approve,treat)
OBJ:V-N (treat,skin)
COMP:V-N(with) (treat,lymphoma)
SUBJ:V_PASS-N (associate,skin)

Analyse 5

                   +--------COMP:N-N(of)-------+                                                                              
                   |           +-MOD_ATT:N-ADJ-+                   +-----------------COMP:V_PASS-N(with)----------------+     
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PA+OBJ:V+----SUBJ:V_PASS-N----+              |     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-V(to) (approve,treat)
COMP:V_PASS-N(with) (approve,lymphoma)
OBJ:V-N (treat,skin)
SUBJ:V_PASS-N (associate,skin)

Analyse 6

                   +--------COMP:N-N(of)-------+                                                                              
                   |           +-MOD_ATT:N-ADJ-+                                   +-----------COMP:N-N(with)-----------+     
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PA+OBJ:V+----SUBJ:V_PASS-N----+              |     
     |             |           |       |       |                   |         |     |                     |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-V(to) (approve,treat)
OBJ:V-N (treat,skin)
COMP:N-N(with) (skin,lymphoma)
SUBJ:V_PASS-N (associate,skin)

Analyse 7

                                                                   +------------------COMP:V_PASS-N(to)-----------------+     
     +------------------------SUBJ:V_PASS-N------------------------+         +----------------MOD_ATT:N-N---------------+     
     |             +--------COMP:N-N(of)-------+                   |         |     +-------------MOD_ATT:N-N------------+     
     |             |           +-MOD_ATT:N-ADJ-+                   |         |     |        +--------MOD_ATT:N-N--------+     
     +----APPOS----+           |       +MOD_ATT+                   |         |     |        |            +-MOD_ATT:N-ADJ+     
     |             |           |       |       |                   |         |     |        |            |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(to) (approve,lymphoma)
MOD_ATT:N-N (lymphoma,treat)
MOD_ATT:N-N (lymphoma,skin)
MOD_ATT:N-N (lymphoma,manifestation)
MOD_ATT:N-ADJ (lymphoma,associate)

Analyse 8

                                                                             +------------------OBJ:V-N-----------------+     
                   +--------COMP:N-N(of)-------+                             |     +-------------MOD_ATT:N-N------------+     
                   |           +-MOD_ATT:N-ADJ-+                             |     |        +--------MOD_ATT:N-N--------+     
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PA+     |        |            +-MOD_ATT:N-ADJ+     
     |             |           |       |       |                   |         |     |        |            |              |     
 __NODE__ , an activator of __SP__ __NODE__ protein , has been approved to treat skin manifestation associated with lymphoma .
APPOS (__NODE__,activator)
COMP:N-N(of) (activator,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-V(to) (approve,treat)
OBJ:V-N (treat,lymphoma)
MOD_ATT:N-N (lymphoma,skin)
MOD_ATT:N-N (lymphoma,manifestation)
MOD_ATT:N-ADJ (lymphoma,associate)